Share This Page
Drug Price Trends for GLYBURIDE MICRO
✉ Email this page to a colleague
Average Pharmacy Cost for GLYBURIDE MICRO
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GLYBURIDE MICRO 3 MG TABLET | 00093-8035-05 | 0.15696 | EACH | 2024-12-18 |
| GLYBURIDE MICRO 6 MG TABLET | 00093-8036-01 | 0.19483 | EACH | 2024-12-18 |
| GLYBURIDE MICRO 1.5 MG TAB | 00093-8034-01 | 0.15996 | EACH | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
GLYBURIDE MICRO Market Analysis and Financial Projection
Market Analysis and Price Projections for Glyburide Micronized
Introduction to Glyburide Micronized
Glyburide, a member of the sulfonylurea class of drugs, is commonly used to manage Type 2 diabetes by stimulating the release of insulin from the pancreas. The micronized form of glyburide is available in various strengths, including 1.5 mg, 3 mg, and 6 mg tablets, and is known for its improved bioavailability compared to non-micronized forms[4].
Market Size and Growth Projections
The global glyburide market has been experiencing significant growth and is anticipated to continue this trend. As of 2023, the market size was valued at several billion USD, and it is projected to reach even higher values by 2031, exhibiting a substantial compound annual growth rate (CAGR)[1][3].
- Segmentation: The market is segmented by type (1.25mg, 2.5mg, 5mg), application (Pediatric Use, Geriatric Use, Others), and geography (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa). The 1.25mg segment and the Pediatric Use segment are expected to see significant growth in the near future[1][3].
Key Drivers and Restraints
Drivers
- Increasing Prevalence of Diabetes: The rising global incidence of Type 2 diabetes is a major driver for the glyburide market. As more people are diagnosed with diabetes, the demand for effective blood-glucose-lowering drugs like glyburide increases.
- Advancements in Formulation: The micronized form of glyburide offers better bioavailability, which enhances its efficacy and patient compliance, contributing to market growth.
- Expanding Product Portfolio: Key companies such as Amneal Pharmaceuticals, Jisheng Medicine, and others are focusing on strategy building and expanding their product portfolios, which helps in capturing a larger market share[1][3].
Restraints
- Side Effects and Risks: Glyburide is associated with a higher risk of hypoglycemia compared to other sulfonylureas, which can be a significant restraint. Studies have shown a 52% greater risk of experiencing at least one episode of hypoglycemia with glyburide compared to other secretagogues[5].
- Regulatory Challenges: The pharmaceutical industry is heavily regulated, and any changes in regulatory policies can impact the market negatively.
Price Analysis
The prices of glyburide micronized tablets vary based on the strength and quantity of the tablets.
- 1.5 mg Tablets: The cost for 100 tablets can range from $23.76 to $24, depending on the pharmacy and any discounts applied[2].
- 3 mg Tablets: The cost for 100 tablets is approximately $28.86 to $29, with bulk purchases offering lower per-unit prices[2].
- 6 mg Tablets: The cost for 100 tablets is around $57.89, reflecting the higher dosage and corresponding higher cost[2].
Geographical Market Analysis
The glyburide market is geographically segmented into North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa.
- Asia-Pacific: This region is expected to see significant growth due to the large population and increasing prevalence of diabetes.
- North America and Europe: These regions have established markets with high demand for diabetes management drugs, driven by advanced healthcare systems and higher awareness of diabetes treatment options[1].
Competitive Landscape
The glyburide market is competitive, with several key players:
- Amneal Pharmaceuticals
- Sanofi Aventis
- Jisheng Medicine
- Double Whale Pharmaceutical
- Bohai Pharmaceutical
- Sunlight Pharmaceutical
- Shapuaisi Pharma
- CR Sanjiu
- Hoechst Canada
- Apotex Corporation
- Avanstra
- Dominion Pharmacal
- Hikma Pharmaceuticals
- Cadila Pharmaceuticals
- Novartis
These companies are focusing on expanding their product portfolios and strengthening their market presence through strategic initiatives[1].
Future Outlook
The future outlook for the glyburide market is positive, driven by the increasing demand for diabetes management solutions. Here are some key points:
- Market Expansion: The market is expected to expand significantly from 2023 to 2031, driven by the growing prevalence of diabetes and advancements in drug formulations.
- Product Innovations: Continuous innovation in the formulation and delivery of glyburide, such as the micronized form, will enhance its efficacy and patient compliance.
- Geographical Growth: Emerging markets, particularly in the Asia-Pacific region, will play a crucial role in the future growth of the glyburide market[1][3].
Key Takeaways
- The global glyburide market is projected to experience significant growth from 2023 to 2031.
- The micronized form of glyburide offers improved bioavailability and efficacy.
- The market is driven by the increasing prevalence of Type 2 diabetes and advancements in drug formulations.
- Key companies are focusing on expanding their product portfolios and market presence.
- The Asia-Pacific region is expected to be a major growth driver.
FAQs
Q: What is glyburide micronized used for? A: Glyburide micronized is used to manage Type 2 diabetes by stimulating the release of insulin from the pancreas.
Q: What are the common strengths of glyburide micronized tablets? A: Glyburide micronized tablets are available in 1.5 mg, 3 mg, and 6 mg strengths.
Q: How does the price of glyburide micronized vary? A: The price varies based on the strength and quantity of the tablets, ranging from approximately $23.76 for 100 tablets of 1.5 mg to $57.89 for 100 tablets of 6 mg.
Q: What are the potential side effects of glyburide? A: Glyburide is associated with a higher risk of hypoglycemia compared to other sulfonylureas.
Q: Which regions are expected to drive the growth of the glyburide market? A: The Asia-Pacific region, along with established markets in North America and Europe, is expected to drive the growth of the glyburide market.
Sources
- Global Glyburide Market Size, Scope And Forecast Report - Market Research Intellect
- Glyburide Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
- Glyburide Market Report 2024 (Global Edition) - Cognitive Market Research
- Glyburide Micronized: Package Insert / Prescribing Info - Drugs.com
- A Systematic Review and Meta-Analysis of Hypoglycemia and ... - Diabetes Care Journal
More… ↓
